4.4 Article

Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for acute lymphoblastic leukemia

Journal

PEDIATRIC BLOOD & CANCER
Volume 60, Issue 7, Pages E38-E41

Publisher

WILEY
DOI: 10.1002/pbc.24483

Keywords

CD4; CD56; dendritic cell; hematodermic tumors; leukemia

Funding

  1. National Institutes of Health, USA [CA21765]
  2. American Lebanese Syrian Associated Charities (ALSAC)

Ask authors/readers for more resources

Dendritic cell leukemia (DCL) or hematodermic tumor is an uncommon subtype of acute leukemia. In contrast to adult cases, children tend to have a less aggressive course. The diagnosis of DCL should be considered when its characteristic morphologic features are present and leukemic cells co-express CD4 and CD56. Cases of DCL among pediatric patients have been reported to respond to therapeutic regimens for acute lymphoblastic leukemia, but details regarding the specifics of therapy are lacking. Pediatr Blood Cancer 2013; 60: E38E41. (c) 2013 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available